| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |